Related content

Sodium iodide symporter in the fight against thyroid cancer

By Kogai Takahiko  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1679-1682

Future Medicine

Access to resources Recommend Favorite

Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer Tissue

By Upadhyay G.  

Breast Cancer Research and Treatment, Vol. 77, Iss. 2, 2003-01 ,pp. : 157-165

Springer Publishing Company

Access to resources Recommend Favorite

The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma

By          

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 669-674

Spandidos Publications

Access to resources Recommend Favorite

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

By              

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 59-66

Spandidos Publications

Access to resources Recommend Favorite

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)

By Fortunati N.   Catalano M.   Marano F.   Mugoni V.   Pugliese M.   Bosco O.   Mainini F.   Boccuzzi G.  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 667-675

Springer Publishing Company

Access to resources Recommend Favorite